171: Prophylaxis of Radiation-Induced Nausea and Vomiting: A Systematic Review and Meta-Analysis of Randomized Controlled Trials  by Li, Wing Sum et al.
CARO 2016 S63 
_________________________________________________________________________________________________________ 
Purpose: Clinical trials in radiation therapy-induced nausea and 
vomiting (RINV) appear to have varied methodologies, endpoints 
and outcome measures. This variability hinders implementation 
of trial results. A comprehensive analysis of RINV trial design 
elements is lacking. 
Methods and Materials: Ovid versions of the Cochrane Central 
Register of Controlled Trials, the Cochrane Database of 
Systematic Reviews, EMBASE and MEDLINE to first quarter 2011 
were searched for randomized trials of RINV management 
strategies. 
Results: From 599 references in the initial database search we 
selected 34 trials for analysis that collectively randomized 4529 
patients. Twenty-eight trials (82%) were published prior to the 
year 2000. Twenty-seven trials (79%) involved multiple fraction 
radiation therapy (RT) and seven (21%) single fraction RT. 
Twenty-four trials (71%) evaluated prophylactic interventions 
and nine (26%) rescue interventions. Thirty-three trials (97%) 
evaluated pharmacologic interventions. Nausea was not defined 
in any trial but was reported as a stand-alone symptom in 26 
trials (76%) and was graded in 20 (59%), with discrete choice 
categorical qualitative scales being the most common method. 
Vomiting was defined in three trials (9%), reported as a stand-
alone symptom in 17 (47%) and was graded in seven (21%), with 
continuous numerical scales being the most common method. 
Retching was defined in three trials (9%), was not reported as a 
stand-alone symptom in any trial and was graded in one (3%). 
Twenty-one trials (62%) created compound symptom measures 
that combined individual symptoms. Fifteen trials (44%) reported 
on “emetic episodes/events” but only nine of these defined 
them. Seventeen trials (50%) reported on complicated endpoints 
such as “response,” “control” and “success” that factored in 
multiple symptom or compound symptom measures, but seven of 
these did not define them comprehensively. Only 10 trials (29%) 
defined a primary endpoint a priori. 
Conclusions: Methodologies, endpoints and outcome measures 
varied considerably among 34 randomized trials in RINV. 
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Purpose: To systematically review the efficacy and safety of 
various antiemetics in prophylaxis of radiation-induced nausea 
and vomiting (RINV). 
Methods and Materials: A literature search of Ovid MEDLINE, 
EMBASE and Cochrane CENTRAL was performed to identify 
randomized controlled trials (RCTs) that evaluated the efficacy 
of prophylaxis for RINV in patients receiving radiotherapy to 
abdomen/pelvis, including total body irradiation (TBI). Primary 
endpoints were complete control of nausea and complete control 
of vomiting during acute and delayed phases. Secondary 
endpoints included use of rescue medication, quality of life and 
incidence of adverse events. 
Results: Seventeen RCTs were identified. Among patients 
receiving radiotherapy to abdomen/pelvis, our meta-analysis 
showed that 5-hydroxytryptamine-3 receptor antagonists (5HT3 
RAs) were significantly more efficacious than placebo and 
dopamine antagonists in both complete control of vomiting (OR 
0.49, 95% confidence interval [CI] 0.33-0.72 and OR 0.17, 95% CI 
0.05-0.58 respectively) and complete control of nausea (OR 0.43, 
95% CI 0.26-0.70 and OR 0.46, 95% CI 0.24-0.88 respectively). 
5HT3 RAs were also more efficacious than rescue therapy and 
dopamine antagonists plus dexamethasone. The addition of 
dexamethasone to 5HT3 RA compared to 5HT3 RA alone provides 
a modest improvement in prophylaxis of RINV. Among patients 
receiving TBI, 5HT3 RA was more effective than other agents 
(placebo, combination of metoclopramide, dexamethasone and 
lorazepam). 
Conclusions: 5HT3 RAs are more effective than other 
antiemetics for prophylaxis of RINV in patients receiving 
radiotherapy to abdomen/pelvis and TBI. Future RCTs should 
investigate the efficacy of newer agents such as aprepitant in 
addition to 5HT3 RAs in prophylaxis of RINV during both acute 
and delayed phases. 
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Purpose: The British Columbia Cancer Agency radiotherapy (RT) 
program started the Prospective Outcomes and Support Initiative 
(POSI) at all six centres in 2013 to collect and utilize patient 
reported outcomes (PROs) for immediate clinical care, quality 
improvement, and research. We sought to explore the feasibility 
and utility of using PRO two years after the start of POSI. 
Methods and Materials: PROs were collected at time of CT 
simulation via tablet or radiation therapist questions, and 2-4 
weeks post-RT over the phone with a registered nurse (RN). 
Descriptive Statistics were used to present accrual and utility of 
PRO data. Comparison in accrual rates between categories was 
performed with chi square tests. Mean differences in time that 
RNs spent on POSI phone calls were compared with t-tests. 
Multivariable logistic regression modeling identified factors 
associated with successful accrual. 
Results: From May 2013 to July 2015, 2849 patients were 
approached by POSI on 5,847 occasions for patients treated with 
RT for bone metastases (81%), brain metastases (12%), and 
incurable lung cancer (7%). The accrual rate for all encounters 
was 76% (n = 4904), ranging from 73% to 87% depending on cancer 
centre (p < 0.001), and highest amount patients with bone 
metastases (78%), followed by lung cancer (75%) and brain 
metastases (65%; p < 0.001). Patients were significantly less 
likely to be successfully accrued at follow up compared to 
baseline (OR = 0.21; 95% CI = 0.18 – 0.24; p < 0.001), as were 
those with brain metastases (OR = 0.50; 0.41 – 0.1; p < 0.001). 
During the study period RNs made 2042 telephone follow up calls, 
totaling 250 RN hours, to both collect PRO, and subsequently use 
these PRO to guide follow up care. The RN-reported mean time 
to complete the follow up call was highest with brain metastases 
(13.1 minutes) compared to lung cancer (8.2 minutes) and bone 
metastases (6.7 minutes), which was highly significant (p < 
0.001). The RN phone calls that required the RN to offer 
additional support were significantly longer than phone calls 
where no support was needed (mean 12.1 versus 6.4 minutes; p 
< 0.001). From this database we have demonstrated similar 
patient reported pain improvement with single versus multiple 
fraction RT (presented previously), and have used data to lead 
quality improvement initiatives, such as identifying patients who 
did not have a dexamethasone weaning protocol. Other quality 
improvement and research utility of the POSI database will be 
described. 
Conclusions: Population-based collection and utilization of PRO 
for clinical care, quality improvement, and research is feasible 
and associated with only a modest increase in resources and 
workload. Further research is needed on how to best incorporate 
